EP1496817A1 - Intraocular lens implant with mirror - Google Patents
Intraocular lens implant with mirrorInfo
- Publication number
- EP1496817A1 EP1496817A1 EP03745386A EP03745386A EP1496817A1 EP 1496817 A1 EP1496817 A1 EP 1496817A1 EP 03745386 A EP03745386 A EP 03745386A EP 03745386 A EP03745386 A EP 03745386A EP 1496817 A1 EP1496817 A1 EP 1496817A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- implant
- mirror
- eye
- mirrors
- visual field
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1648—Multipart lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1659—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having variable absorption coefficient for electromagnetic radiation, e.g. photochromic lenses
Definitions
- the present invention relates to an intraocular insert for implantation in the interior of the human eye and, more particularly, to an intraocular implant with at least one mirror.
- Macular degeneration is a disorder in which the central retinal area (the macula) degenerates, e.g., because of age (age-related macular degeneration, or AMD), diabetic retinopathy, ocular vascular accidents or diseases, retinal dystrophies (such as, for example, cone dystrophy), central nervous system (CNS) diseases, etc.
- AMD age-related macular degeneration
- CNS central nervous system
- central vision is used for focused vision, such as with reading, for example.
- the extraocular muscles move the globe of the eye so as to adjust the eye so that the image of an object being looked at impacts always on the point of central vision that occupies only a small fraction (less than 10%) of the retina, that is, the macula.
- the bulk of the retina is used for peripheral vision, which serves primarily for orientation in space and the visual acuity is not as sharp as that of the central vision of the macula.
- central vision provides a relatively small field of view with very high resolution for perception of details
- peripheral vision provides a wide field of view with relatively low resolution, providing sufficient information for navigation and detection of targets of interest.
- AMD AMD is a common cause of visual loss among people over the age of 60.
- the risk of developing AMD is nearly 30% in those over age 75.
- the intraocular implants with a telescope include that these implants can not be used in both eyes — one eye (the implanted eye) is needed for improved central vision and one (the other eye, without the implant) for peripheral vision.
- the IOL with the telescope also known as an implantable miniaturized telescope, or IMT
- the IOL with the telescope has a black posterior part that does not allow light to enter the eye, except through the telescope, as that would cause stray light and glare.
- the pupil has to be narrowed so that the pupil covers at least some of the black part of the IMT. With use of the IOL with the telescope there is a considerable reduction in the amount of light that enters the eye.
- such an intraocular implant could be used for treatment of diseases and processes that cause constriction of peripheral vision, including inherited retinal disorders causing retinitis pigmentosa, and glaucoma as examples.
- Further applications for such an intraocular implant include increased image magnification, increased illumination and the elimination of certain wavelengths of light, such as ultraviolet light, as well as allowing depth perception with vision from a single eye by creating monocular stereopsis.
- An implant providing increased illumination and increased magnification would be desirable also for use in the treatment of regular cataract patients, who do not have retinal problems.
- U.S. Pat. No. 4,759,761 to Portnoy discloses a catadioptric intraocular lens containing interior mirrored surfaces forming a folded telescope.
- the device of the Portnoy patent is not structured so as be useful for other disease processes such as diabetic maculopathy, retinitis pigmentosa or advanced glaucoma.
- the mirrors cover the entire pupillary aperture, it tries to achieve a maximal increased central image visual field while covering and obscuring the natural peripheral visual field and thus it is almost impossible to examine the retina or treat it, beyond the blockage of peripheral vision.
- the device of Portnoy which was never built or used in clinical practice, can only be implanted in one eye.
- an intraocular implant for implantation in the interior of a human eye for treatment of defects in central vision, while preserving peripheral vision, and also for treatment of defects in the peripheral visual field .
- an intraocular implant for implantation into the interior of an eye, the eye having a pupil, an iris, and a retina, the retina having a macula, the implant including: a body member, the body member having an anterior surface and a posterior surface, and having optical properties, and, at least one mirror, wherein the at least one mirror is contained within the body member.
- an intraocular implant including a body member, the body member having a plurality of surfaces, and having optical properties, and, at least one mirror, wherein the at least one mirror is contained within the body member.
- the implant is adapted for a position of fixation into the eye, the position of fixation being selected from the group consisting of anterior chamber fixation, posterior chamber fixation, capsular bag fixation, scleral fixation, intra-vitreous fixation, sulcus fixation, and iris supported fixation.
- the anterior surface is of convex configuration.
- the posterior surface is of convex configuration.
- the implant further includes at least one loop for fixation in the eye.
- the at least minOr is configured so as to reflect a viewed image onto a preferred position of the retina of the eye.
- the at least one mirror is constructed from a plurality of separate component parts.
- the at least one mirror is adapted for multi-focal focusing.
- the at least one mirror is adapted for correction of higher order optical aberrations. According to still further features in the described preferred embodiments the at least one mirror consists of two mirrors.
- the two mirrors are a central mirror and a peripheral mirror.
- the central mirror has a shape with at least one characteristic selected from the group consisting of convex, concave, astigmatic, prismatic, rounded, pointed, aspheric, irregular, fixed shape, and adjustable shape.
- the peripheral mirror has a shape with at least one characteristic selected from the group consisting of a complete circumferential ring, a partial circumferential ring, convex, concave, aspheric, circular, elliptical, astigmatic, prismatic, fixed shape, and adjustable shape.
- the peripheral mirror is at least partially hidden beneath the iris of the eye.
- the central mirror has at least one aperture therethrough.
- the implant further includes at least one adjustment mechanism for adjusting at least one feature of the at least one mirror.
- the adjustment mechanism is selected from the group consisting of a micromechanical mechanism, thermal mechanism, laser operated mechanism, ultrasound mechanism, an electromagnetic mechanism, a photoelectric mechanism, and a piezoelectric mechanism.
- the at least one feature is selected from the group consisting of shape of the at least one mirror, curvature of the at least one mirror, and position of the at least one mirror.
- the implant is adapted for the treatment of presbyopia by the adjustment of the feature and position of the at least one mirror.
- the at least one adjustment mechanism is operable from outside the eye.
- the at least one adjustment mechanism is operable from outside the eye by an adjustment control element selected from the group consisting of a laser, ultrasound, light, a frequency emitter, an electromagnetic force element, a temperature control element, and a pressure control element.
- the at least one prism is adapted so as to divert at least a portion of a viewed image to a preferred part of the retina of the eye.
- the at least one prism is adapted so as to produce a continuity on the retina of the eye of a reflected visual image with a transmitted, unreflected image.
- the at least one prism is selected from the group consisting of a holographic lens and a fresnel.
- the at least one mirror is coated with a reflectance altering material for altering at least one light reflectance property of the at least one mirror.
- the implant further includes at least one filter for adjusting the light transmission through the implant.
- the implant further includes at least one lens.
- the implant further includes a conformer, the conformer adapted for implantation into a structure of the eye, the conformer and the body member being adapted such that the body member is capable of being inserted and fixed into the conformer.
- the conformer further includes at least one optical component. According to still further features in the described preferred embodiments the conformer has at least one optical property.
- the conformer is non-foldable.
- the implant is adapted so that the body member may be changed within the conformer.
- the body member is solid.
- the body member encloses an inner cavity.
- the at least one mirror is adapted for transmission of a laser beam for medical purposes.
- the implant is adapted ' for changing a visual field.
- the implant is adapted for altering at least one spectrum of wavelength of light entering the eye. According to still further features in the described preferred embodiments the implant is adapted for treatment of a disorder of central vision.
- the implant is adapted for treatment of a disorder of peripheral vision.
- the disorder of central vision is a tapetoretinal degeneration.
- the implant is adapted for treatment of a (normal) age related cataract.
- the peripheral visual field is preserved.
- the implant is adapted so as to be capable of being implanted into the eye containing the natural crystalline lens.
- any one of the plurality of surfaces of the body member is at least partially of a configuration selected from the group consisting of convex, concave, planar, aspheric, spheric, irregular, asymmetric, astigmatic, prismatic, holographic, , fresnel, and graded index.
- the implant includes more than two mirrors.
- the more than two mirrors is of a number chosen from the group consisting of three mirrors, four mirrors, five, or six mirrors; that is the implant includes three, four, five, or six mirrors.
- the implant further includes at least one adjustment mechanism for adjusting at least one feature of the at least one mirror, wherein the at least one adjustment mechanism is operable from inside the eye.
- the filter is placed in a location selected from the group consisting of: on the at least one mirror, before the at least one mirror, after the at least one mirror, and so as to affect light that does not reflect on the at least one mirror.
- the implant has a central axis
- the implant further includes an optical diverting element for diverting light entering the implant to the at least one mirror, wherein the at least one mirror is placed at a location off the central axis.
- the implant includes at least two mirrors.
- the implant further includes a conformer, the conformer adapted for implantation into a structure of the eye, the conformer and the body member being adapted such that the body member is capable of being inserted and fixed into the conformer, and the location of insertion being selected from the group consisting of a capsular bag, a vitreous, an iris support, an anterior chamber and a posterior chamber.
- the implant is adapted so as to permit monocular stereopsis.
- the at least one mirror includes at least three mirro ' rs, such that light reflected from a first mirror and a second mirror of the at least three mirrors reflects onto a third mirror, the first mirror and the second mirror being configured so as to be of different shapes so as to transmit simultaneously two different images onto the retina.
- the implant is configured for fixation into a location in the eye selected from the group consisting of a capsular bag, a sulcus, a vitreous, an anterior chamber, and a posterior chamber.
- the implant further includes at least one lens, wherein the at least one lens is placed in a location selected from the group consisting of within the implant, external to the implant and external to the implant with an attachment to the implant.
- the implant is adapted for treatment of a disorder of the peripheral visual field.
- the implant is adapted for treatment of a disorder of restricted peripheral vision.
- the present invention successfully addresses the shortcomings of the presently known configurations by providing an intraocular implant containing at least one mirror, which can be used in the treatment of any ocular problem, including disorders of central and peripheral vision.
- the IOL with a telescope is intended not to allow peripheral light to enter the eye as it causes visual disturbances, thus narrowing the pupillary opening, in the present invention the pupil is not affected and the pupil functions normally.
- Peripheral vision is permitted, in contrast to either the IOL with a telescope or the catadioptric intraocular lens of Portnoy, which tries to magnify and increase the visual field of the central magnified image, while totally obscuring the peripheral image.
- the present invention permits a full normally sized peripheral visual field with a magnified central image for seeing precise objects such as for reading while permitting normal peripheral vision for general orientation in space.
- the extraocular muscles move the globe of the eye so as to position the eye so that the image of an object always impacts on the point of central vision, that is, the macula.
- the remainder of the retina is used for peripheral vision, which serves primarily for orientation in space.
- central vision provides a relatively small field of view with very high resolution for perception of details
- peripheral vision provides a wide field of view with relatively low resolution, providing sufficient information for navigation and detection of targets of interest.
- Another advantage, among many others, of the present invention is the easing of restrictions of patient selection criteria for implantation, as use of the device is no longer restricted to patients that have similar visual acuities in both eyes, and visual acuity lower than a certain standard in both eyes.
- the present invention can be implanted in a patient that has central visual problems in both eyes without taking into account the relative visual acuity of the other eye. Further it can be used for both dry-type as well as wet-type macular degeneration.
- FIG. 1 illustrates a horizontal section of an eye with a preferred embodiment of the intraocular insert of the present invention in place
- FIG. 2 is a schematic diagram illustrating the principles of a preferred embodiment of the present invention
- FIG. 3 is a frontal view of a preferred embodiment of the intraocular insert according to the present invention
- FIG. 4 is a horizontal section of an alternate preferred embodiment of the intraocular insert according to the present invention
- FIG. 6 is a horizontal section of a further alternate preferred embodiment of the intraocular insert according to the present invention.
- FIG. 8 is a horizontal section of another alternate preferred embodiment of the intraocular insert according to the present invention.
- FIG. 9 is a horizontal section of a further alternate preferred embodiment of the intraocular insert according to the present invention.
- FIG. 10 is a horizontal section of another alternate preferred embodiment of the intraocular insert according to the present invention.
- FIG. 11A is a horizontal section of another alternate preferred embodiment of the intraocular insert according to the present invention.
- FIG 14 is a horizontal section of another alternate preferred embodiment of the intraocular insert according to the present invention.
- FIG 16 is a horizontal section of yet another alternate preferred embodiment of the intraocular insert according to the present invention
- FIG. 17 is a horizontal section of still another alternate preferred embodiment, of the intraocular insert according to the present invention.
- FIG. 18 is a horizontal section of yet another alternate preferred embodiment of the intraocular insert according to the present invention
- FIG. 19 is a horizontal section of yet another alternate preferred embodiment of the intraocular insert according to the present invention
- FIG. 20 is a horizontal section of a still further alternate preferred embodiment of the intraocular insert according to the present invention.
- FIG. 22 is a horizontal section of a still further alternate preferred embodiment of the intraocular insert according to the present invention.
- the present invention is of an intraocular insert for implantation in the interior of the human eye and, more particularly, to an intraocular implant containing at least one mirror, which can be used in the treatment of regular cataracts, and of disorders of central, as well as of disorders of peripheral, vision.
- the present invention can be used to treat AMD and other macular degenerations.
- Modifications of the intraocular insert can be used for the treatment of other ocular disorders including retinitis pigmentosa and glaucoma and other causes of impaired peripheral vision, for example.
- Figure 1 illustrates a horizontal section of a human eye (20), illustrating the cornea 22, the iris 24, the pupil 26, the zonula 28, the vitreous 30 and the retina 32.
- implant 10 can be implanted in various compartments and by various techniques including fixation in the anterior or posterior chamber, capsular bag, by sulcus fixation, scleral fixation, intravitreous fixation or iris supported as non-limiting examples.
- the intraocular implant 10 includes a body member 12, of generally convexo- convex or convexo-plano configuration; that is, its front or anterior face 14 facing the anterior side of eye 20 is of convex configuration, and similarly its rear or posterior face 16 facing the posterior side of eye 20 is of convex (or planar) configuration; or may be of any other geometrical configuration.
- anterior face 14 or posterior face 16 may be at least partially of convex, concave, planar, spheric, aspheric, irregular, asymmetric, astigmatic, prismatic, holographic or graded index configuration, or some combination thereof.
- the dioptic and other optical properties of body member 12 are one parameter determining the visual correction of implant 10. Both surfaces may be of any dioptic power and may include additional optical properties such as a prism, fresnel, hologram, index graded optics or aspheric, as non-limiting examples.
- implant 10 may also include at least one loop 11 for holding and fixing implant 10 inside the capsular bag 36 or in any other location inside of eye 20.
- Implant 10 fills the entire lenticular capsular bag 36 in certain configurations and applications, and in other configurations and applications does not fill the entire lenticular capsular bag 36.
- various configurations of the at least one loop 11 fixes implant 10 within the capsular bag.
- loop 11 is preferably configured as a ring.
- body member 12 of implant 10 is at least one mirror. Two are illustrated in Figure 1 and are designated 40 and 42. This is for exemplary purposes only, and in other configurations only one mirror, or more than two, as illustrated below, are employed.
- the principle and object of implant 10 containing the at least one mirror is to improve vision, by changing the image on the retina.
- implant 10 can be used to enlarge the central image on the retina of eye 20 in an individual affected with an ocular disorder such as AMD and can be used to reflect the image to a desired position on retina 32.
- the arrangement of mirrors typically gives a wider aperture of vision and allows more flexibility of the geometric arrangement than a refracting telescopic system using lenses and avoids chromatic and other optical aberration, does not depend on the index of refraction of the media and enables preservation of the normal peripheral vision of the eye.
- mirror is used to denote a reflective element, and to include any type of reflective element. Specifically included are such reflective elements including: a reflective mirror; a refractive lens with a posterior reflecting surface, wherem the anterior surface of the refractive lens may be either planar, spherical or aspherical, irregular, astigmatic, or prismatic, as non-limiting examples; and, a reflective holographic element or Fresnel surface, which may also be mounted on a posterior surface of a planar, curved, spherical or aspherical, irregular, astigmatic, prismatic element.
- the at least one mirror may be concave, convex, aspheric, spheric, irregular, astigmatic, or prismatic or of any other geometric shape.
- the dioptric and other optical properties of body member 12 are one parameter determining the visual correction of implant 10, which affects both the central and peripheral vision.
- the second parameter is based on the properties of the optical performance of at least one mirror.
- the properties of body member 12 determine the correction of peripheral vision, but it affects also the central vision, and the magnification accomplished by the arrangement of the at least one mirror determines central vision. Normal light is transmitted directly and normally through body member 12 while central light is diverted to the at least one mirror. As such, "natural" or "regular" peripheral vision is permitted.
- the phrase “natural” or “regular” peripheral vision is used to mean vision that is created by light that does not pass through or reflect upon the at least one mirror. This light may however be modified by other optical means (including increasing, decreasing, diverting or moving it as non-limiting examples) using optical systems located on the surface, inside implant 10 or connected to implant 10 from the outside.
- implant 10 may further include lenses or other optical means to modify the central and/or the peripheral visual images.
- central mirror 40 may be convex or concave, and rounded or pointed and therefore take various shapes including, but not limited to shapes such as: U or Pi, V or E, as well as any other aspheric, irregular, astigmatic, or prismatic or irregularly shaped surface.
- Second mirror 42 is a circumferential ring (complete or partial, generally circular or elliptical, for example ) hidden (completely or partially) beneath iris 24 as is illustrated in Figures 1 and 3.
- an artificial pupillary aperture can be created by the mirror.
- Like reference numerals refer to like parts throughout the figures of the drawing. In such a position mirror 42 does not affect the passage of light rays into eye 20 as mirror 42 is under the iris 24 which already blocks the entry of light.
- Central mirror 40 which is preferably about 0.1 to 4.5 mm, and more preferably 0.2 to 3.5 mm in size, and most preferably about 0.5 to 2 mm in size, can be placed in front of the macula of retina 32.
- mirror 40 may provide a small obstruction blocking light rays from directly impacting on the macula of retina 32, the macula is the portion of retina 32 that is damaged by the extant disease process in any case.
- central mirror 40 has an aperture (which may be centrally placed, as a non-limiting example) to allow direct and reflected light rays to pass therethrough and impact on retina 32.
- mirror 40 has a configuration that appears like / ⁇ rather than ⁇ for example.
- the at least one mirror may be constructed from more than one component part or piece.
- the peripheral mirror 42 too may be constructed from separate pieces placed in various locations and not necessarily be continuous.
- the size of the entire implant 10 is preferably about 4-10 mm in diameter, along the horizontal axis of the eye, (and most preferably 6-10 mm) by about 1-6 mm (and most preferably 4-5 mm), along the longitudinal axis of the eye, apart from any attached loops for fixation.
- the width of implant 10 along the longitudinal axis of the eye is preferably less than the 5 mm size of the capsular bag, when implanted therein. When fixed in the vitreous, there is more space, and implant 10 may be of a larger size.
- Second mirror 42 is preferably about 0.2 to 5 mm in longest diameter.
- Figure 10 illustrates a preferred embodiment of the present invention in which the arrangement of the at least one mirror takes the form of an intraocular Cassegrain telescope.
- Parallel light rays 44 of object 46 that are blocked from impacting directly on retina 32 because they are blocked by the coated back of central mirror 40 reflect off second mirror 42 which is preferably a circumferential ring as described hereinabove.
- the light rays reflected off mirror 42 is diverted to mirror 40 and from there reflected onto retina 32 where the photoreceptor cells transmit a now magnified image to the brain via the optic nerve.
- the mirror arrangement improves central vision, normal peripheral vision is permitted, in contrast to the device of U. S. Patent No. 4,759, 761, which only magnifies the central image and does not permit peripheral vision.
- the light 70 that passes through the device but does not impact on mirrors 42 and 40 is that of the normal peripheral vision, thus implant 10 allows the eye to see a central magnified image as well as a normal sized peripheral image.
- Figure 11 illustrates a further preferred embodiment similar to that illustrated in Fig. 10.
- the placement of mirror 42 differs in these 2 embodiments.
- mirror 42 is located more peripherally inside implant 10 such that the inner edges 72 of mirror 42 effectively create a pupillary opening.
- the peripheral placement of inner edges 72 of mirror 42 obstructs a smaller portion of the retina by mirror 42 permitting greater peripheral vision.
- the patient sees normal peripheral vision through a fixed pupillary opening defined by the inner edges 72 of mirror 42.
- Figure 4 illustrates a further preferred embodiment of the present invention in which the shape or curvature of the at least one mirror, for example, mirror 40 or mirror 42, is adjustable.
- the at least one mirror Operationally connected to the at least one mirror (in various alternate configurations, either mirror 40 and/or mirror 42) is at least one adjustment mechanism 50.
- Adjustment mechanism 50 is operational from outside of or inside eye 20 to change the curvature of mirror 40 and/or 42 so as to change the magnification of image 48.
- Further adjustment mechanism 50 in certain configurations is adapted to move the position of the at least one mirror, for example in an anterior/posterior direction, to the sides, rotated, or tilted. Such movement in position of the at least one mirror 40 or 42 is particularly useful in the treatment of presbyopia.
- the 10 further includes at least one optical diverting element that moves the location of the image to another location, such as a prism 52.
- prism is used to include any optical element that gives a prismatic effect or displaces or moves the image to a new location.
- Prism 52 is used for example to divert all or portions of the vision, for example both central image 48 as well as the peripheral vision to other parts of the macula or of retina 32.
- At least one prism 52 can be placed in varying positions within implant 10 as illustrated in Figure 5 by the illustrated second prism 54.
- the at least one prism (e.g. 52) can be used to avoid an improper overlap of the reflected image 48 with other images on retina 32.
- the at least one prism e.g.
- the at least one prism 52 can be used to displace a peripheral image and make it in continuity with the magnified central image 48.
- the image from the central vision is now magnified, while the peripheral visual field is normal and placed in continuity with the central image (as seen in Fig. 21).
- the at least one prism 52 pushes aside the peripheral image to make room for the large central image and to allow for a single continuos smooth full picture.
- the at least one prism 52 may be a separate element inside implant 10 (in those configurations wherein implant 10 is hollow) or the at least one prism 52 may be a holographic lens, a fresnel, axicon (a conical lens or rotationally symmetric prism), or be produced by a difference of index of refraction of the various materials of implant 10, or any other optical method for displacing an image, that is, changes the location of the transmitted image on the retina.
- the at least one prism 52 may be inside or outside body member 12.
- the at least one mirror is coated with a material that alters the light reflectance properties of the at least one mirror.
- a material that alters the light reflectance properties of the at least one mirror can be used for example, to collect more light and intensify the light transmission and the contrast of the reflected image as is desirable in patients with AMD.
- alternate coatings can be used to block a certain spectrum of light (e.g., ultraviolet) so as to sharpen the image and also to reduce damage to retina 32.
- implant 10 in certain preferred embodiments, contains at least one filter to change the spectrum of light impacting on retina 32.
- the filter can change the spectrum in the central visual field, the peripheral field or both.
- implant 10 can be used to, as non-limiting examples, magnify, minify, move, or invert an image, increase or decrease the visual field, or introduce a prismatic inversion or change the intensity and/or spectrum of light entering the eye.
- peripheral vision occurs in other disorders of the eye, such as (inherited) tapetoretinal degenerations causing retinitis pigmentosa, and glaucoma for example.
- Peripheral vision involves the ability to perceive objects, gross movement, or sharp contrasts toward the sides and edges of the visual field.
- Use of a configuration of implant 10 in which the at least one mirror increases the visual field for example through use of a wide angle mirror such as is conventionally employed in rear view car mirrors, can be used to treat such disorders and increase their visual field which otherwise suffer from reduced peripheral vision.
- Figures 12-15 illustrate further alternate preferred embodiments of the present invention in which there are alternative arrangements of the at least one mirror.
- the principles of the embodiments illustrated in Figs. 12-15 are the same as those illustrated in Figs. 1 and 10, however in the embodiments of Figs. 12-14, additional mirrors are employed.
- Figs. 12 and 13 for example, 4 mirrors are employed [labeled 40, 42, 74, and 76], and in Fig. 14 five mirrors are shown [labeled 40, 42, 74, 76, and 78],.
- other numbers of mirrors, more or less, can be used.
- the light can be diverted from side to side with implant 10 as seen in Fig. 12 for example, or may be in any other suitable configuration.
- the specific arrangement of the mirrors including the size, mirror shape and configuration, mirror surface shape and configuration, placement, curvature, numbers and arrangement of the at least one mirror, is chosen so as to change the visual image in the desired manner, such as magnifying or minifying, or changing the location of the image, or changing the spectrum of light of the image, as non-limiting examples.
- Optical image 48 will be changed according to curvature, shape, structure, placement and other properties of the mirrors and the path which the reflected light follows.
- any of the at least one mirrors may have any of various shapes including those described hereinabove such as a complete circumferential ring, and a partial circumferential ring, a rectangle, or any other regular or irregular geometric shape, and the surfaces of each mirror can be of various configurations including convex, concave, rounded, pointed, aspheric, circular, elliptical, irregular, fixed shape, and adjustable shapes, as non-limiting examples or a combination of the above.
- Fig. 15 illustrates yet another preferred embodiment of the intraocular implant according to the present invention. This embodiment employs an optical element, 80 to divert light beam 44 from the central axis 82 of eye 20 to mirror 42 located at a position off central axis 82.
- Optical element 80 may be, for example, a prism or any other optical element such as a hologram, graded index material, a fresnel, axicon, or other similar optical element that can be used to divert an optical beam.
- Off axis mirror 42 can comprise a small or a larger portion of the pupillary opening 26, but in general is not always a fully circumferential mirror as described hereinabove.
- Light diverted to off axis mirror 42 is from there reflected to at least one additional mirror 40 and from there onto retina 32.
- Optical image 48 will be changed according to curvature, shape, structure, placement and other properties of the mirrors and the path which the reflected light follows. This design further preserves mostly undisturbed normal peripheral vision through light that passes through pupil 26 but that is not diverted through optical element 80 and mirror 42.
- Figure 6 illustrates an alternate preferred embodiment of the implant 10 according to the present invention in which a carrier or conformer 56 is first inserted into a structure of the eye 20 (for example, to replace the patient's lens) and then body member 12 is inserted into conformer 56 as an inner insert 58.
- inner insert 58 including body member 12 containing the at least one mirror can be more easily changed so as to change the treatment as the underlying disease changes and progresses.
- Further inner insert 58 can be rotatable from outside eye 20 or the position of inner insert 58 inside the eye can be changed in any other manner from outside the eye, by adding a mechanical or other mechanism, to rotate insert 58 within conformer 56 .
- Conformer 56 may, in certain configurations, also contain various optical components such as at least one lens or mirror or conformer 56 itself may have various optical properties. As. is described hereinabove for body member 12 conformer 56 may be constructed from a hard (non-foldable) or soft (foldable) material. Conformer 56 placed in any structure of the eye, generally preferably into the lenticular capsule as a non-limiting example, and, in certain configurations, has at least one loop (not illustrated) , analogous to the at least one loop 11 illustrated in Fig. 9 for fixation to an eye structure. Conformer 56 may be implanted not only in the capsular bag, but also, in other configurations, in other sites such as the vitreous, iris support, anterior chamber or posterior chamber as non-limiting examples.
- Figure 7 illustrates an alternate embodiment of implant 10 in which body member 12 is hollow rather than solid. Also envisioned are embodiments in which body member 12 is divided into several compartments.
- body member 12 consists of an outer casing 60, fabricated from glass or any other biocompatible and suitable material, enclosing an inner cavity 62.
- body member 12 is isolated from other ocular structures by a solid cover which is non-permeable to the toxic molecules.
- anterior and posterior surfaces 14 and 16 each have both outer and inner surfaces, the inner surfaces being those. closest toward cavity 62.
- Each of these surfaces may be of any geometrical configuration.
- each may be at least partially of convex, concave, planar, spheric, aspheric, irregular, asymmetric, prismatic, holographic or graded index configuration, or some combination thereof.
- the at least one mirror (two are illustrated in Figure 7 and are designated 40 and 42) are placed and fixed (as necessary with fixation elements) within cavity 62.
- Cavity 62 may be filled with any suitable material depending on the index of refraction desired, including for example, air or other gases, water, oil, or other transparent liquids, another solid component, or a graded index of refraction material.
- the material in cavity 62 is also chosen based on the chemical properties of the material.
- a material is preferably inert, biocompatible, non-toxic, and suitable for the particular structure and configuration of implant 10.
- Fig. 8 shows an alternate configuration of implant 10. Such a configuration finds particular use, as non-limiting examples, in the treatment of a regular cataract, and in AMD.
- two mirrors, 40 and 42 are illustrated.
- Mirror 40 for example has a planar configuration and mirror 42 is not fully circumferential.
- Implant 10 according to the present invention can be used in both eyes. As opposed to the intraocular implant with a telescope and the catadioptric intraocular lens of Portnoy there is no interference with the pupil size, peripheral vision and there is no severe anisoconia. In contrast to the intraocular implant with a telescope and the catadioptric intraocular lens of Portnoy, where there is a correlation between the magnification ability, index of refraction of the media and the maximal image size, which confers a limitation, with implant 10 of the present invention, the magnification can be increased, decreased or adapted, and the image size can be increased, decreased or adapted in an unlimited fashion and it does not depend on the index of refraction of the media.
- treatment with laser or photodynamic therapy can be performed through implant 10, with the laser, for example, passing directly through implant 10 and not through the mirror system, or by reflecting off the at least one mirror.
- the at least one mirror in some configurations is adapted for transmission of a laser beam for medical purposes.
- the laser beam may be, for example, PDT, an argon laser, a krypton laser or a YAG laser or any other such laser as is used medically.
- implant 10 may find application for uses other than for treating disorders of central vision such as AMD, or those of peripheral vision, such as retinitis pigmentosa.
- implant 10 may be adapted use to treat a patient suffering from a regular (age-related) cataract or for after cataract surgery.
- Implant 10 may be used in "healthy" eyes to magnify images, to increase or decrease the amount of light entering, or to change the spectrum of wavelengths and position of light permitted to enter the eye.
- Fig. 16 illustrates yet another preferred embodiment of the intraocular implant 10 according to the present invention in which the at least one mirror is employed to divert light within eye 20 to achieve three dimensional visual perception through monocular stereopsis.
- Mirrors 42 and 74 are placed at different specific precise distances from central mirror 40 such that each creates a different image , 48 and 78 respectively on the center (macula) of retina 32 of a single eye 20.
- Mirrors 42 and 74 create 2 different light paths, 84 and 86 respectively that preferably impact on mirror 40 resulting in reflected rays 85 and 87 respectively which create images 48 and 88 respectively.
- images 48 and 88 impact on retina 32 simultaneously and in phase, a three-dimensional image is created and perceived in the brain using only one eye.
- monocular stereopsis can also be achieved using additional mirrors to divert at least one image or by placing mirror 40 at a different position or axis relative to mirrors 42 and 74.
- mirrors 42 and 74 may be of different shapes or configurations so as to transmit simultaneously two distinct images 48 and 88 to the same retina 32.
- peripheral vision is preserved.
- Fig. 17 illustrates a further preferred embodiment of the present invention.
- implant 10 is modified in such a way so as to enable it to be implanted in at least one eye . which has already undergone surgery, such as for treatment of cataract, with implantation of a "regular" intraocular lens implant.
- capsular bag 36 has been emptied during prior cataract surgery and regular intraocular lens implant 90 has been previously implanted into capsular bag 36 using at least one loop 92.
- Implant 10 according to the present invention has been subsequently implanted into capsular bag 36 using at least one loop 11 as a "piggy-back implant".
- implant 10 is modified in such a way so as to enable it to be implanted in at least one eye which has already undergone surgery, such as for treatment of cataract, with implantation of a "regular" intraocular lens implant.
- implant 10 containing at least one mirror 40 according to the present invention is placed in and located in the sulcus 94 so that the at least one loop 11 is located at an angle between iris 24 and ciliary body 96 and not in capsular bag 36.
- implant 10 as illustrated in Fig. 18 is employed and designed in " a manner similar to (and optically adapted to) that illustrated in Fig. 17.
- the preferred embodiment illustrated in Fig. 19 is further identical (and optically adapted to) in all respects to those illustrated in Figs. 17 and 18, except that implant 10 is placed in the anterior chamber 98 of eye 20.
- the at least one loop 11 for fixation are located at the anterior chamber angle 100.
- Fig. 20 illustrates a further preferred embodiment of the present invention.
- implant 10 is modified in such a way so as to include at least one lens placed either within or external to implant 10.
- the configuration of optical effects is produced not only through use of at least one mirror 40, but also through at least one lens.
- Multiple lenses are illustrated in Fig. 20 as components 102 and 104.
- the at least one lens may be introduced at different locations in the optical path of light in different configurations according to the specific purpose of the at least one lens. It can be located before reflecting on the at least one mirror or after reflecting on the at least one mirror, including after all mirrors, or between mirrors, in those configurations with a plurality of mirrors, or any combination thereof.
- the lenses may be located external to implant 10 as illustrated as lenses 102 or within implant 10 as illustrated in Fig 20 as 104.
- Lens 102 may be at any location within eye 20 that is or is not connected to implant 10 or connected only in part.
- the at least one lens may be employed with implant 10 for purposes including increasing or decreasing magnification, visual field changes, changing of location of the light on the retina, or for improving or inducing optical aberrations, as non-limiting examples.
- Other optical elements such as a hologram, fresnel, or graded index element, as non-limiting examples, can also be used in place of lenses 102 or 104.
- the word lens is used to include any optical element that changes the way the light travels.
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
Description
Claims
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/108,458 US6902577B2 (en) | 2002-03-29 | 2002-03-29 | Intraocular lens implant with mirror |
US108458 | 2002-03-29 | ||
US10/316,006 US6913620B2 (en) | 2002-03-29 | 2002-12-11 | Intraocular lens implant with mirror |
US316006 | 2002-12-11 | ||
PCT/IL2003/000244 WO2003082155A1 (en) | 2002-03-29 | 2003-03-20 | Intraocular lens implant with mirror |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1496817A1 true EP1496817A1 (en) | 2005-01-19 |
EP1496817A4 EP1496817A4 (en) | 2012-05-02 |
EP1496817B1 EP1496817B1 (en) | 2016-03-16 |
Family
ID=28677835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03745386.7A Expired - Lifetime EP1496817B1 (en) | 2002-03-29 | 2003-03-20 | Intraocular lens implant with mirror |
Country Status (4)
Country | Link |
---|---|
US (1) | US6913620B2 (en) |
EP (1) | EP1496817B1 (en) |
AU (1) | AU2003227305A1 (en) |
WO (1) | WO2003082155A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040233383A1 (en) * | 2002-12-16 | 2004-11-25 | Sandler Richard H. | Artificial iris and lens apparatus |
US7001427B2 (en) * | 2002-12-17 | 2006-02-21 | Visioncare Ophthalmic Technologies, Inc. | Intraocular implants |
US6972032B2 (en) * | 2003-01-14 | 2005-12-06 | Visioncare Ophthalmic Technologies Inc. | Intraocular lens implant |
US20040193264A1 (en) * | 2003-03-31 | 2004-09-30 | Richard Lindstrom | Compound AC IOL system |
US20050288784A1 (en) * | 2004-06-23 | 2005-12-29 | Peyman Gholam A | Bifocal intraocular telescope for low vision correction |
US20060015180A1 (en) * | 2003-06-06 | 2006-01-19 | Peyman Gholam A | Intraocular telescope |
JP4038454B2 (en) * | 2003-07-31 | 2008-01-23 | 株式会社ニデック | Intraocular lens |
US7842086B2 (en) * | 2005-01-07 | 2010-11-30 | Visioncare Ophthalmic Technologies, Inc. | Mirror implant |
US20070027541A1 (en) * | 2005-07-26 | 2007-02-01 | Visioncare Ophthalmic Technologies Inc. | Intraocular devices and methods for implantation thereof |
US8088161B2 (en) * | 2005-07-28 | 2012-01-03 | Visioncare Ophthalmic Technologies Inc. | Compressed haptics |
US7424687B2 (en) * | 2005-11-16 | 2008-09-09 | Lsi Corporation | Method and apparatus for mapping design memories to integrated circuit layout |
WO2007113832A2 (en) * | 2006-04-03 | 2007-10-11 | Isaac Lipshitz | Intra-ocular implant |
US7918886B2 (en) * | 2006-05-25 | 2011-04-05 | Visioncare Ophthalmic Technologies Inc. | Double insertion intraocular implant |
US20100145445A1 (en) * | 2008-12-10 | 2010-06-10 | Visioncare Opthalmic Technologies Inc. | Anti-glare solutions for intraocular implants |
GB2468367B (en) | 2009-05-27 | 2011-02-16 | See Again Europ Ltd | Intraocular lens systems and methods |
WO2011102719A1 (en) | 2010-02-17 | 2011-08-25 | Akkolens International B.V. | Adjustable chiral ophthalmic lens |
US9931200B2 (en) | 2010-12-17 | 2018-04-03 | Amo Groningen B.V. | Ophthalmic devices, systems, and methods for optimizing peripheral vision |
US8454159B1 (en) | 2012-05-23 | 2013-06-04 | Donald M. Cislo | Method and devices for treatment of macular degeneration visual impairment |
AU2014228357B2 (en) | 2013-03-11 | 2018-08-23 | Johnson & Johnson Surgical Vision, Inc. | Intraocular lens that matches an image surface to a retinal shape, and method of designing same |
US9636215B2 (en) | 2014-03-10 | 2017-05-02 | Amo Groningen B.V. | Enhanced toric lens that improves overall vision where there is a local loss of retinal function |
CN106714731B (en) | 2014-04-21 | 2019-09-27 | 阿莫格罗宁根私营有限公司 | Improve Ophthalmoligic instrument, the system and method for peripheral vision |
US10588738B2 (en) | 2016-03-11 | 2020-03-17 | Amo Groningen B.V. | Intraocular lenses that improve peripheral vision |
WO2017182878A1 (en) | 2016-04-19 | 2017-10-26 | Amo Groningen B.V. | Ophthalmic devices, system and methods that improve peripheral vision |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0162573A2 (en) * | 1984-04-17 | 1985-11-27 | Sanford D. Hecht | Eye implant |
EP0242043A1 (en) * | 1986-03-13 | 1987-10-21 | Allergan, Inc | Catadioptric intraocular lens |
US5728156A (en) * | 1996-08-06 | 1998-03-17 | Prism Opthalmics, L.L.C. | Prismatic intraocular lenses and related methods of in situ alteration of their optical characteristics |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5166711A (en) * | 1987-06-01 | 1992-11-24 | Valdemar Portney | Multifocal ophthalmic lens |
US4878910A (en) * | 1988-06-13 | 1989-11-07 | Koziol Jeffrey E | Intraocular lens assembly |
US5139325A (en) * | 1991-01-25 | 1992-08-18 | Oksman Henry C | Wide depth of focus power add to intraocular and contact lenses |
US5423929A (en) * | 1993-10-27 | 1995-06-13 | Allergan, Inc. | Intraocular lenses and methods for producing same |
FR2744908B1 (en) * | 1996-02-20 | 1998-06-12 | W K Et Associes | MYOPIC INTRAOCULAR IMPLANT |
US6171337B1 (en) * | 1999-03-31 | 2001-01-09 | Miles A. Galin | Positive power anterior chamber ocular implant |
-
2002
- 2002-12-11 US US10/316,006 patent/US6913620B2/en not_active Expired - Lifetime
-
2003
- 2003-03-20 AU AU2003227305A patent/AU2003227305A1/en not_active Abandoned
- 2003-03-20 WO PCT/IL2003/000244 patent/WO2003082155A1/en not_active Application Discontinuation
- 2003-03-20 EP EP03745386.7A patent/EP1496817B1/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0162573A2 (en) * | 1984-04-17 | 1985-11-27 | Sanford D. Hecht | Eye implant |
EP0242043A1 (en) * | 1986-03-13 | 1987-10-21 | Allergan, Inc | Catadioptric intraocular lens |
US5728156A (en) * | 1996-08-06 | 1998-03-17 | Prism Opthalmics, L.L.C. | Prismatic intraocular lenses and related methods of in situ alteration of their optical characteristics |
Non-Patent Citations (1)
Title |
---|
See also references of WO03082155A1 * |
Also Published As
Publication number | Publication date |
---|---|
US20030187502A1 (en) | 2003-10-02 |
AU2003227305A1 (en) | 2003-10-13 |
EP1496817A4 (en) | 2012-05-02 |
EP1496817B1 (en) | 2016-03-16 |
WO2003082155A1 (en) | 2003-10-09 |
US6913620B2 (en) | 2005-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6902577B2 (en) | Intraocular lens implant with mirror | |
US6913620B2 (en) | Intraocular lens implant with mirror | |
US7008448B2 (en) | Intraocular implant for retinal diseases | |
CA2921118C (en) | Intraocular lens system | |
JP4598783B2 (en) | Intraocular device with multiple focusing capabilities / optics | |
CA1280922C (en) | Catadioptric intraocular lens | |
ES2342656T3 (en) | MULTIFOCAL INTRAOCULAR LENTILLA. | |
US9610153B2 (en) | Intra-ocular implant | |
NL2008105C2 (en) | Intraocular lens. | |
EP0162573A2 (en) | Eye implant | |
US20030158599A1 (en) | Accommodating intraocular lens with elongated suspension structure | |
JP2007513709A (en) | Multifocal intraocular lens and method of making and using the same | |
KR20090020588A (en) | Aspheric intraocular lens and method for designing such iol | |
JP2009532176A (en) | Intraocular lens with perspective adjustment | |
WO1996039106A1 (en) | Asymmetric bifocal intraocular lens | |
JP4931932B2 (en) | Multifocal prosthesis and method of manufacturing using the same | |
US20120071972A1 (en) | Multiphase eyecare | |
JP4568727B2 (en) | Intraocular lens device for improving visual acuity during retinal disease | |
WO1994013225A1 (en) | Intraocular achromatic lens | |
Hamid et al. | Advanced Technology Intraocular Lenses | |
WO2002094131A2 (en) | Low surface-glare intraocular lenses | |
KR20240073973A (en) | Ophthalmic implant for correcting vision with an adjustable optical device, method of manufacturing the same, and method of using the same | |
Lu et al. | Optical performance of the super-reversed intraocular lens | |
van den Berg et al. | Ciliary corona and lenticular halo | |
JPH01501842A (en) | intraocular bifocal lens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20041025 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20120330 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61F 2/16 20060101AFI20120326BHEP |
|
17Q | First examination report despatched |
Effective date: 20130430 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20151022 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 780516 Country of ref document: AT Kind code of ref document: T Effective date: 20160415 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 60348670 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 14 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20160316 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160617 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160316 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 780516 Country of ref document: AT Kind code of ref document: T Effective date: 20160316 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160331 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160316 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160316 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160316 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160316 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160316 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160316 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160718 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160316 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160316 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 60348670 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160316 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160316 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160331 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160331 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160320 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160316 |
|
26N | No opposition filed |
Effective date: 20161219 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160616 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20170329 Year of fee payment: 15 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160316 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20170327 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20170330 Year of fee payment: 15 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20030320 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160316 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160316 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160320 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160316 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 60348670 Country of ref document: DE |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20180320 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181002 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180320 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180331 |